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a GIS can answer: What is at a particular
location? Where is a location that meets a
particular condition? What has changed at
the location since a specific time or event?
What spatial patterns exist? What ifspecif-
ic events occur or a population is exposed?
Many of these applications are useful for
environmental health research.
Using GIS to describe potential envi-
ronmental exposures by location, race, and
socioeconomic factors within specific pop-
ulation groups is essential to documenting
problems related to environmental equity.
NIEHS has begun a GIS project to identi-
fy and gather environmental exposure and
demographic databases to examine this
issue. Examples of exposure databases
include several EPA files such as the Toxic
Releases Inventory (TRI), which includes
yearly data on the release of 300 toxic
chemicals, and CERCLIS and RCRIS,
which include information on the location
ofwaste sites. The demographic informa-
tion is contained in the 1990 U.S. Census.
Exposure databases include spatial infor-
mation that allows for an analysis ofpoten-
tial toxic exposures by state, county, and
census block groups and can be correlated
with the available census variables includ-
ing race and income level. Currently, these
analyses are being carried out in several
North Carolina counties as well as counties
in California and West Virginia. The
results will be presented at the
"Symposium on Health Research and
Needs to Ensure Environmental Justice,"
scheduled for February 10-12 in
Washington, DC.
Last year NIEHS funded a study con-
ducted by the NCDEHNR that took
advantage ofGIS methodology to identify
populations at high risk for childhood lead
poisoning. In this study, numerous risk
factors with spatial identifiers known to be
related to childhood lead poisoning were
identified and entered into a model to
highlight geographic areas that contain
environmental and socioeconomic risk fac-
tors for lead poisoning. The data on
socioeconomic risk factors came from the
1990 U.S. Census. These risk factors
included per capita income, percent hous-
ing built before 1950, percent African-
American population, a poverty index
(which was a combination of percent
female-headed households with children
under 18 years, percent homes owner-
occupied, and percent ofchildren under 6
years old in poverty), percent of popula-
tion receiving public assistance, and medi-
an house value. Other databases were eval-
uated for their use in the model, including
TRI to identify environmental point
source releases of lead, the road network
system to identify proximity to major
roads, and EPA's STORET and AIRS
databases, which include water and air
quality data. The analysis was performed
for several counties within North Carolina
down to the census-block group level. The
results yielded a spectrum oflow- to high-
risk block groups within the counties.
This methodology needs to be validated in
the field by sampling predicted high- and
low-risk populations and comparing the
actual risk measured by blood lead levels
with the risk predicted by the model.
Although GIS has not been used exten-
sively in environmental epidemiology,
studies to generate and test hypotheses are
beginning to emerge. As environmental
exposure databases compatible with GIS
are developed, linkages will be possible
with health and disease data. Much ofthe
health and disease data can be related to
spatial/geographic variables; this primarily
involves the use ofaddresses ofresidence or
information to identify census tract or
block, county, or zip code. Databases of
interest include cancer and birth defects
registries, mortality files, hospital discharge
files, and other survey data or registries.
The NCDEHNR has embarked on several
environmental epidemiologic studies using
GIS. One such study includes an analysis
of brain cancer (from the North Carolina
Cancer Registry) and proximity of resi-
dence to electric power lines (surrogate of
exposure to electric and magnetic fields).
Examples of other studies that might be
considered include childhood asthma relat-
ed to environmental exposures, breast can-
cer related to environmental and demo-
graphic factors, and birth defects related to
living near hazardous waste sites.
Through a Glass, Darkly
Lately it appears that even a substance as
ubiquitous as glass wool (fiberglass) is not
insulated from controversy. The potential
listing ofglass wool in the Seventh Annual
Report on Carcinogens has government
and industry scientists at odds over the
material's potential for causing cancer.
The Annual Report on Carcinogens is
mandated by Congress as part of the
Community Mental Health Extension
Centers Act of 1978 and prepared by the
National Toxicology Program. The report
lists all substances that are either known
carcinogens or may reasonably be antici-
pated to be carcinogens. Glass wool has
been recommended for listing in the report
because of evidence of its carcinogenicity
in experimental animals (rats and ham-
sters) published in an International Agency
for Research on Cancer monograph in
1988. Following a 1990 notice in the
FederalRegisterthat the NTP was planning
to list glass wool in the annual report, the
North American Insulation Manufacturers
Association (NAIMA) submitted several
petitions to the Secretary of Health and
Human Services requesting a deferral of
the listing pending a reexamination of the
scientific studies assessing the carcinogenic-
ity ofglass wool and review of the criteria
used by the NTP to list substances. A reex-
amination and review are underway.
Currently the criteria for listing a sub-
stance in the Annual Report on Carcin-
ogens are based on those used by IARC
for classifying carcinogens. For a sub-
stance to be considered a known carcino-
gen, the criteria are "sufficient evidence of
carcinogenicity" from studies in humans
"which indicates a causal relationship
between the agent and human cancer."
For a substance to be reasonably anticipat-
ed to be a carcinogen, the criteria are
"limited evidence ofcarcinogenicity" from
studies in humans, "which indicates that
causal interpretation is credible, but that
alternative explanations, such as chance,
bias, or confounding, could not adequate-
ly be excluded," or "sufficient evidence of
carcinogenicity" from studies in experi-
mental animals "which indicates that an
increased incidence of malignant tumors
in multiple species or strains, or in multi-
ple experiments (preferably with different
routes ofadministration or using different
dose levels), or to an unusual degree with
regard to incidence, site or type oftumor,
or age at onset." Additional evidence may
be provided by data concerning dose-
response effects as well as information on
mutagenicity or chemical structure.
The controversy surrounding the list-
ing ofglass wool concerns whether inhala-
tion studies in the rodents are the only
appropriate model in rats bywhich to eval-
uate glass wool's carcinogenic potential in
humans. The bone of contention between
government and industry is the route of
exposure to glass wool by which rats are
subjected during testing. The rat is an
obligate nose breather, whereas humans
breathe through the nose and mouth. In
addition to inhalation studies, rats and
hamsters were given intraperitoneal injec-
tions and intratracheal instillations ofglass
wool fibers. According to NAIMA, this
route of administration artificially places
high concentrations offibers at a target site
and avoids the natural defense mechanism
of the rat. NAIMA contends that only
studies ofrodents exposed to glass wool by
inhalation should be considered in evaluat-
ing its toxicity. Although tumors have been
produced in most glass wool inhalation
studies in rodents, tumors have not been
observed at statistically significant levels
when compared to controls.
Intraperitoneal injection studies in rats
and intratracheal instillation studies in rats
and hamsters have produced significant
44 Environmental Health Perspectivesnumbers of tumors, including mesothe-
liomas, sarcomas, and, rarely, carcinomas.
It is on the basis ofthese studies that IARC
reported that although there is inadequate
evidence for the carcinogenicity of glass
wool in human epidemiology studies, there
is sufficient evidence in experimental ani-
mals to consider glass wool potentially car-
cinogenic to humans. The view of the
NTP is that listing a substance in the
annual report is a method ofhazard identi-
fication and one of the first steps taken in
determining the risk associated with expo-
sure to an environmental agent. The listing
of glass wool in the Annual Report on
Carcinogens is based on a "strength ofthe
evidence" evaluation which the NTP con-
cluded glass wool met.
The selection ofglass wool for listing as
a substance reasonably anticipated to be a
carcinogen has been reviewed by two fed-
eral scientific review groups that evaluate
candidate substances to ensure they meet
the criteria for inclusion in the annual
report. Both groups determined that glass
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